SBS-226 is a dual mu opiate receptor (MOR) partial agonist and delta opiate receptor (DOR) full antagonist in development for opiate use disorder (OUD) and Opiate Withdrawal Syndrome (OWS) Grant ...

A new study found a link between new popular GIP/GLP-1 receptor agonists and a reduced rate of overdose or intoxication in people with opioid and alcohol use disorders. New popular weight-loss and ...